News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jiangsu Hengrui Medicine Co. Ltd. and Crown Bioscience, Inc. Announce Antibody Partnership


1/13/2012 2:55:00 PM

January 13, 2012 -- Jiangsu Hengrui Medicine has entered a strategic partnership with Crown Bioscience to discover and commercialize a novel monoclonal antibody, which will be developed for China and global markets. Hengrui signed the deal with Crown’s subsidiary, CrownBio Taicang Biologics Division. CrownBio, which will lead the discovery program and deliver a humanized IND candidate, will receive research support and a success-based incentive payment. More details....

Stock Symbol: (SHA: 600276)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES